In RA, the activation of OC is limited to localized joints and interacts with inflammation, forming a complex network of “immunity/inflammation-OC overactivation-bone metabolism imbalance,” which ultimately drives the progressive erosion and destruction of bones and joints in RA patients (6). The gene discussed is BGLAP; the disease is rheumatoid arthritis.